Literature DB >> 25759360

[Pneumococcal vaccination in adults: recommendations from the Italian Society of Respiratory Medicine (SIMeR) and the Italian Society of Hygiene, Preventive Medicine and Public Health (SItI)].

Francesco Blasi1, Stefano Aliberti, Paolo Bonanni, Marco Mantero, Anna Odone, Carlo Signorelli.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25759360

Source DB:  PubMed          Journal:  Epidemiol Prev        ISSN: 1120-9763            Impact factor:   1.901


× No keyword cloud information.
  5 in total

1.  The 2016 Lifetime Immunization Schedule, approved by the Italian scientific societies: A new paradigm to promote vaccination at all ages.

Authors:  Paolo Bonanni; Giampietro Chiamenti; Giorgio Conforti; Tommasa Maio; Anna Odone; Rocco Russo; Silvestro Scotti; Carlo Signorelli; Alberto Villani
Journal:  Hum Vaccin Immunother       Date:  2017-11-02       Impact factor: 3.452

Review 2.  Pneumococcal vaccination and chronic respiratory diseases.

Authors:  Filipe Froes; Nicolas Roche; Francesco Blasi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-05

3.  Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolated from hospitalized patients with community-acquired pneumonia in Italy.

Authors:  Marta Di Pasquale; Stefano Aliberti; Chara Azzari; Maria Moriondo; Francesco Nieddu; Francesco Blasi; Marco Mantero
Journal:  SAGE Open Med       Date:  2017-07-16

4.  Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy.

Authors:  Marco Mantero; Stefano Aliberti; Chiara Azzari; Maria Moriondo; Francesco Nieddu; Francesco Blasi; Marta Di Pasquale
Journal:  Ther Adv Respir Dis       Date:  2017-08-31       Impact factor: 4.031

5.  Potential impact of combined influenza and pneumococcal vaccines on the severity of respiratory illness in COVID-19 infection among type 2 diabetic patients.

Authors:  Amr Shaaban Hanafy; Waseem M Seleem; Hany A Elkattawy
Journal:  Clin Exp Med       Date:  2022-01-22       Impact factor: 5.057

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.